FindTrial
Sign In

The value of routine biopsy during percutaneous kyphoplasty for the treatment of vertebral compression fractures

The value of routine biopsy during percutaneous kyphoplasty for the treatment of vertebral compression fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17013227
Enrollment
Unknown
Registered
2017-11-03
Start date
2017-11-30
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vertebral compression fractures

Interventions

Treatment group:percutaneous kyphoplasty

Sponsors

Beijing Chao-Yang Hospital, China Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Focal back pain related to the location of vertebral compression fractures; (2) Collapse inferior to 2/3 of the standard thickness of vertebral body with an intact posterior wall; (3) Visual analogue scale (VAS) > 6 scores.;Inclusion criteria: (1) Focal back pain related to the location of vertebral compression fractures; (2) Collapse inferior to 2/3 of the standard thickness of vertebral body with an intact posterior wall; (3) Visual analogue scale (VAS) > 6 scores.;Inclusion criteria: (1) Focal back pain related to the location of vertebral compression fractures; (2) Collapse inferior to 2/3 of the standard thickness of vertebral body with an intact posterior wall; (3) Visual analogue scale (VAS) > 6 scores.;Inclusion criteria: (1) Focal back pain related to the location of vertebral compression fractures; (2) Collapse inferior to 2/3 of the standard thickness of vertebral body with an intact posterior wall; (3) Visual analogue scale (VAS) > 6 scores.;Inclusion criteria: (1) Focal back pain related to the location of vertebral compression fractures; (2) Collapse inferior to 2/3 of the standard thickness of vertebral body with an intact posterior wall; (3) Visual analogue scale (VAS) > 6 scores.

Exclusion criteria

Exclusion criteria: (1) Coagulation disorders; (2) Bone cement allergies; (3) Active infections.;Exclusion criteria: (1) Coagulation disorders; (2) Bone cement allergies; (3) Active infections.;Exclusion criteria: (1) Coagulation disorders; (2) Bone cement allergies; (3) Active infections.;Exclusion criteria: (1) Coagulation disorders; (2) Bone cement allergies; (3) Active infections.;Exclusion criteria: (1) Coagulation disorders; (2) Bone cement allergies; (3) Active infections.

Design outcomes

Primary

MeasureTime frame
Pathological type of biopsies;—

Countries

China

Contacts

Public ContactQingjun Su;Qingjun Su;Qingjun Su;Qingjun Su;Qingjun Su ;;;;

Department of Orthopaedics, Beijing Chao-Yang Hospital, China Capital Medical University;Department of Orthopaedics, Beijing Chao-Yang Hospital, China Capital Medical University;Department of Orthopaedics, Beijing Chao-Yang Hospital, China Capital Medical University;Department of Orthopaedics, Beijing Chao-Yang Hospital, China Capital Medical University;Department of Orthopaedics, Beijing Chao-Yang Hospital, China Capital Medical University

qjsurex@sohu.com;qjsurex@sohu.com;qjsurex@sohu.com;qjsurex@sohu.com;qjsurex@sohu.com+86 13911923253;+86 13911923253;+86 13911923253;+86 13911923253;+86 13911923253

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026